Harvard Bioscience Inc HBIO
$6.00
+0.84%
at last close
Financials (TTM)
- Revenue
- $85.53 million
- Net Income
- $-9,784,000
- Net Margin
- -11.44%
- Return on Equity
- -97.39%
- Debt-to-Equity
- 3.60
- P/E Ratio
- —
- Price / Book
- 2.69
- Price / Sales
- 0.32
Over the trailing twelve months, Harvard Bioscience Inc generated revenue of $85.53 million and net income of $-9,784,000, a net margin of -11.44%.
At the last closing price of $6.00, HBIO trades at 0.32 times sales, with a market capitalization of $27.06 million.
Key Stats
- Last Close
- $6.00
- Market Cap
- $27.06 million
- 52-Week Range
- $2.81 – $9.46
- Average Volume
- 32K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.